• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒刺突蛋白识别不同哺乳动物物种血管紧张素转换酶2(ACE2)受体的结构分析及其对病毒感染的易感性

Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection.

作者信息

Koley Tirthankar, Madaan Shivani, Chowdhury Sanghati Roy, Kumar Manoj, Kaur Punit, Singh Tej Pal, Ethayathulla Abdul S

机构信息

Department of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029 India.

Department of Computer Science, Jamia Millia Islamia, New Delhi-110025, India.

出版信息

3 Biotech. 2021 Feb;11(2):109. doi: 10.1007/s13205-020-02599-2. Epub 2021 Feb 1.

DOI:10.1007/s13205-020-02599-2
PMID:33552834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7848672/
Abstract

UNLABELLED

The pandemic COVID-19 was caused by a novel Coronavirus-2 (SARS-CoV-2) that infects humans through the binding of glycosylated SARS-CoV-2 spike 2 protein to the glycosylated ACE2 receptor. The spike 2 protein recognizes the N-terminal helices of the glycosylated metalloprotease domain in the human ACE2 receptor. To understand the susceptibility of animals for infection and transmission, we did sequence and structure-based molecular interaction analysis of 16 ACE2 receptors from different mammalian species with SARS-CoV-2 spike 2 receptor binding domain. Our comprehensive structure analysis revealed that the natural substitution of amino acid residues Gln24, His34, Phe40, Leu79 and Met82 in the N-terminal α1 and α2 helices of the ACE2 receptor results in loss of crucial network of hydrogen-bonded and hydrophobic interactions with receptor binding domain of SARS-CoV-2 spike protein. Another striking observation is the absence of N-glycosylation site Asn103 in all mammals and many species, lack more than one N-linked glycosylation site in the ACE2 receptor. Based on the loss of crucial interactions and the absence of N-linked glycosylation sites we categorized as highly susceptible while and Capra hircus as moderately susceptible species for infection. Similarly, the , and are categorized as low susceptible with as least susceptible species for SARS-CoV-2 infection.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s13205-020-02599-2.

摘要

未标记

大流行的新冠病毒病(COVID-19)由一种新型冠状病毒2(SARS-CoV-2)引起,该病毒通过糖基化的SARS-CoV-2刺突2蛋白与糖基化的血管紧张素转换酶2(ACE2)受体结合来感染人类。刺突2蛋白识别人类ACE2受体中糖基化金属蛋白酶结构域的N端螺旋。为了解动物对感染和传播的易感性,我们对来自不同哺乳动物物种的16种ACE2受体与SARS-CoV-2刺突2受体结合域进行了基于序列和结构的分子相互作用分析。我们的全面结构分析表明,ACE2受体N端α1和α2螺旋中氨基酸残基Gln24、His34、Phe40、Leu79和Met82的自然取代导致与SARS-CoV-2刺突蛋白受体结合域的关键氢键和疏水相互作用网络丧失。另一个显著观察结果是,所有哺乳动物和许多物种中均不存在N-糖基化位点Asn103,并且许多物种的ACE2受体中缺少不止一个N-连接糖基化位点。基于关键相互作用的丧失和N-连接糖基化位点的缺失,我们将[具体物种1]和[具体物种2]归类为高度易感感染物种,而[具体物种3]和山羊归类为中度易感物种。同样,[具体物种4]、[具体物种5]和[具体物种6]被归类为低易感物种,[具体物种7]为对SARS-CoV-2感染最不易感的物种。

补充信息

在线版本包含可在10.1007/s13205-020-02599-2获取的补充材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/a79990c958ab/13205_2020_2599_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/1b38035c953a/13205_2020_2599_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/619c4d294a03/13205_2020_2599_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/0cbc752cec76/13205_2020_2599_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/c4009f582d5a/13205_2020_2599_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/35a9b75e63c2/13205_2020_2599_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/95ffb7010b15/13205_2020_2599_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/a79990c958ab/13205_2020_2599_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/1b38035c953a/13205_2020_2599_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/619c4d294a03/13205_2020_2599_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/0cbc752cec76/13205_2020_2599_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/c4009f582d5a/13205_2020_2599_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/35a9b75e63c2/13205_2020_2599_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/95ffb7010b15/13205_2020_2599_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7851257/a79990c958ab/13205_2020_2599_Fig7_HTML.jpg

相似文献

1
Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection.新冠病毒刺突蛋白识别不同哺乳动物物种血管紧张素转换酶2(ACE2)受体的结构分析及其对病毒感染的易感性
3 Biotech. 2021 Feb;11(2):109. doi: 10.1007/s13205-020-02599-2. Epub 2021 Feb 1.
2
Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.评估血管紧张素转化酶 2 介导的 SARS-CoV-2 在物种间的进入。
J Biol Chem. 2021 Jan-Jun;296:100435. doi: 10.1016/j.jbc.2021.100435. Epub 2021 Feb 19.
3
Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells.基于禽类细胞中 ACE2 和 TMPRSS2 的表达,开发一种用于研究动物物种对 SARS-CoV-2 复制易感性的体外模型。
Virology. 2022 Apr;569:1-12. doi: 10.1016/j.virol.2022.01.014. Epub 2022 Feb 12.
4
Differential susceptibility of SARS-CoV-2 in animals: Evidence of ACE2 host receptor distribution in companion animals, livestock and wildlife by immunohistochemical characterisation.动物中 SARS-CoV-2 的易感性差异:通过免疫组织化学特征鉴定,伴侣动物、家畜和野生动物中 ACE2 宿主受体的分布证据。
Transbound Emerg Dis. 2022 Jul;69(4):2275-2286. doi: 10.1111/tbed.14232. Epub 2021 Jul 26.
5
Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.分析 N 连接糖基化在 SARS-CoV-2 受体 ACE2 的细胞表面表达、功能和结合特性中的作用。
Microbiol Spectr. 2021 Oct 31;9(2):e0119921. doi: 10.1128/Spectrum.01199-21. Epub 2021 Sep 8.
6
Predicting susceptibility to SARS-CoV-2 infection based on structural differences in ACE2 across species.基于不同物种 ACE2 结构差异预测对 SARS-CoV-2 感染的易感性。
FASEB J. 2020 Dec;34(12):15946-15960. doi: 10.1096/fj.202001808R. Epub 2020 Oct 4.
7
Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.人类 ACE2 结构的变异可能会影响其与 SARS-CoV-2 刺突蛋白的结合。
J Med Virol. 2020 Sep;92(9):1580-1586. doi: 10.1002/jmv.25832. Epub 2020 Apr 15.
8
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike.人血管紧张素转换酶 2 糖基化在与 SARS-CoV-2 刺突结合中的双重性质。
Proc Natl Acad Sci U S A. 2021 May 11;118(19). doi: 10.1073/pnas.2100425118.
9
Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.SARS-CoV-2 刺突突变的分子动力学模拟分析及宠物和野生动物 ACE2 感染风险评估。
Comput Biol Chem. 2022 Feb;96:107613. doi: 10.1016/j.compbiolchem.2021.107613. Epub 2021 Dec 1.
10
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.常见突变对 SARS-CoV-2 刺突 RBD 及其配体人 ACE2 受体结合亲和力和动力学的影响。
Elife. 2021 Aug 26;10:e70658. doi: 10.7554/eLife.70658.

引用本文的文献

1
Identification of new pharmacophore against SARS-CoV-2 spike protein by multi-fold computational and biochemical techniques.采用多重计算和生化技术鉴定针对 SARS-CoV-2 刺突蛋白的新型药效团。
Sci Rep. 2024 Feb 13;14(1):3590. doi: 10.1038/s41598-024-53911-6.
2
Synthesis of multivalent sialyllactose-conjugated PAMAM dendrimers: Binding to SARS-CoV-2 spike protein and influenza hemagglutinin.多价唾液酸乳糖偶联的 PAMAM 树枝状大分子的合成:与 SARS-CoV-2 刺突蛋白和流感血凝素的结合。
Int J Biol Macromol. 2023 Aug 15;246:125714. doi: 10.1016/j.ijbiomac.2023.125714. Epub 2023 Jul 7.
3
Label-Free Saliva Test for Rapid Detection of Coronavirus Using Nanosensor-Enabled SERS.

本文引用的文献

1
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.全面表征 SARS-CoV-2 人受体血管紧张素转换酶 2 的 N-和 O-糖基化。
Glycobiology. 2021 May 3;31(4):410-424. doi: 10.1093/glycob/cwaa101.
2
Structural and functional modelling of SARS-CoV-2 entry in animal models.SARS-CoV-2 入侵动物模型的结构和功能建模。
Sci Rep. 2020 Sep 28;10(1):15917. doi: 10.1038/s41598-020-72528-z.
3
SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.SARS-CoV-2 宿主嗜性:主要细胞因子的计算分析。
使用纳米传感器增强的表面增强拉曼光谱技术进行无标记唾液检测以快速检测冠状病毒
Bioengineering (Basel). 2023 Mar 22;10(3):391. doi: 10.3390/bioengineering10030391.
4
Viral target and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: Molnupiravir, nirmatrelvir, and remdesivir.基于病毒靶点和代谢的原理,联合使用最近获得授权的小分子 COVID-19 药物:莫努匹韦、奈玛特韦和瑞德西韦。
Fundam Clin Pharmacol. 2023 Aug;37(4):726-738. doi: 10.1111/fcp.12889. Epub 2023 Mar 25.
5
SARS-CoV-2 Affects Both Humans and Animals: What Is the Potential Transmission Risk? A Literature Review.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对人类和动物均有影响:潜在传播风险是什么?文献综述
Microorganisms. 2023 Feb 17;11(2):514. doi: 10.3390/microorganisms11020514.
6
GPS Tracking of Free-Roaming Cats () on SARS-CoV-2-Infected Mink Farms in Utah.GPS 追踪犹他州感染 SARS-CoV-2 的水貂养殖场中自由放养的猫。
Viruses. 2022 Sep 27;14(10):2131. doi: 10.3390/v14102131.
7
Genomic and structural mechanistic insight to reveal the differential infectivity of omicron and other variants of concern.揭示奥密克戎和其他关注变体差异感染性的基因组和结构机制见解。
Comput Biol Med. 2022 Nov;150:106129. doi: 10.1016/j.compbiomed.2022.106129. Epub 2022 Sep 22.
8
Comparative Structural Analysis of Human ACE2 Receptor with Spike Protein of SARS-CoV-2 Variants: Implications to Understand Infectivity of the Virus.人ACE2受体与SARS-CoV-2变体刺突蛋白的比较结构分析:对理解病毒感染性的启示
Adv Appl Bioinform Chem. 2022 Jun 16;15:21-27. doi: 10.2147/AABC.S360787. eCollection 2022.
9
Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2.基于受体结合域突变对 SARS-CoV-2 与人 ACE2 相互作用影响的计算预测。
Mol Divers. 2022 Dec;26(6):3309-3324. doi: 10.1007/s11030-022-10392-x. Epub 2022 Feb 9.
10
Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater.追踪在纽约市废水中检测到的隐匿性 SARS-CoV-2 谱系。
Nat Commun. 2022 Feb 3;13(1):635. doi: 10.1038/s41467-022-28246-3.
Virus Res. 2020 Nov;289:198154. doi: 10.1016/j.virusres.2020.198154. Epub 2020 Sep 9.
4
Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus.在一个兽医校园内,与一群新冠肺炎患者密切接触的猫和狗未感染严重急性呼吸综合征冠状病毒2。
One Health. 2020 Dec;10:100164. doi: 10.1016/j.onehlt.2020.100164. Epub 2020 Aug 29.
5
Emerging coronaviruses: Genome structure, replication, and pathogenesis.新型冠状病毒:基因组结构、复制与发病机制
J Med Virol. 2020 Oct;92(10):2249. doi: 10.1002/jmv.26234. Epub 2020 Aug 2.
6
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.糖基化 SARS-CoV-2 刺突蛋白与人血管紧张素转换酶 2 受体的病毒-受体相互作用。
Cell Host Microbe. 2020 Oct 7;28(4):586-601.e6. doi: 10.1016/j.chom.2020.08.004. Epub 2020 Aug 24.
7
Coronaviruses in cats and other companion animals: Where does SARS-CoV-2/COVID-19 fit?猫和其他伴侣动物中的冠状病毒:SARS-CoV-2/COVID-19 属于哪种?
Vet Microbiol. 2020 Aug;247:108777. doi: 10.1016/j.vetmic.2020.108777. Epub 2020 Jun 23.
8
Drug repurposing approach to target FtsZ cell division protein from Salmonella Typhi.从伤寒沙门氏菌中靶向 FtsZ 细胞分裂蛋白的药物重定位方法。
Int J Biol Macromol. 2020 Sep 15;159:1073-1083. doi: 10.1016/j.ijbiomac.2020.05.063. Epub 2020 May 15.
9
Cell entry mechanisms of SARS-CoV-2.SARS-CoV-2 的细胞进入机制。
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734. doi: 10.1073/pnas.2003138117. Epub 2020 May 6.
10
COVID-19 pandemic-a focused review for clinicians.COVID-19 大流行——临床医生重点关注。
Clin Microbiol Infect. 2020 Jul;26(7):842-847. doi: 10.1016/j.cmi.2020.04.023. Epub 2020 Apr 25.